Archive

Year: 2008

All Year: 2008 Articles

Newest first · Page 312

Wall St. Begins To Buy-In To $120 Oil

The idea that oil might hit $120 was the stuff of fairy tale and lying around the poker table. At least up until now. A new Reuters poll of analysts shows that many of…

Douglas A. McIntyre · 18 years ago

UBS (UBS) Presages US Bank Earnings (C)(MER)(MS)

At UBS (NYSE: UBS) it all hit the fan today. Marcel Ospel, the bank’s chairman, is on the way out. The financial firm wrote-off another $19 billion. The company plans to raise $15 billion…

Douglas A. McIntyre · 18 years ago

Media Digest 4/1/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

According to Reuters, US car sales for March are likely to be off sharply. Reuters writes that Microsoft (MSFT) will not raise its bid for Yahoo!  (YHOO) Reuters reports that UBS (UBS) will take…

Douglas A. McIntyre · 18 years ago

Asia Markets 4/1/2008 (SNE)(CN)(SNP)

Markets in Asia were mixed The Nikkei rose 1% to 12,656. Sony (SNE) roe 2.3% to 4060. Toshiba rose 3.2% to687. The Hang Seng was up .1% to 22,878. China Netcom (CN) rose 1.1%…

Douglas A. McIntyre · 18 years ago

Dell Slashes & Burns, Right In Its Back Yard (DELL, AMAT)

Dell Inc. (NASDAQ: DELL) has announced additional actions in its previous restructuring in its attempt to smooth its operating model, rationalize its operations and improve profitability and cash flow.  In short, costs are coming…

Douglas A. McIntyre · 18 years ago

Lehman Intends $3 Billion Capital Raise in Preferred Sales (LEH)

Lehman Brothers Holdings Inc. (NYSE: LEH) has just announced that it has "responded to investor interest" with the intent to offer to offer 3,000,000 shares of Non-Cumulative Perpetual Convertible Preferred Stock with a $1,000…

Douglas A. McIntyre · 18 years ago

Cell Genesys Scores Takeda Deal (CEGE)

Cell Genesys, Inc. (NASDAQ: CEGE) has announced a global alliance with Takeda Pharmaceutical Company Limited in Japan.  The companies will develop and commercialize Cell Genesys’ GVAX immunotherapy for prostate cancer, which is the company’s…

Douglas A. McIntyre · 18 years ago

The 52-Week Low Club (SGP)(MRK)(MO)

Schering-Plough (SGP) Bad news on key cholesterol drug marketed with Merck. Shares fall to $14 from 52-week high of $33.81. Merck (MRK) Pulled down for the same reason. Sells off to $36.82 from 52-week…

Douglas A. McIntyre · 18 years ago

Wall St. Votes Against Big Apple (AAPL) iPhone Prediction

A Wall St. research firm suggested that Apple (NYSE: AAPL) would sell 45 million iPhones in 2009 which would bring in $11.7 billion, according to Silicon Alley Insider. Investors don’t think so. Apple’s shares…

Douglas A. McIntyre · 18 years ago

SPAC IPO FILING: Fintech Acquisition Corp. (TBBK)

Fintech Acquisition Corp., a SPAC, or special purpose acquisition company, has filed to come public via an IPO. The filing shows a target of $100 million. Each $10 unit will consist of unit of…

Douglas A. McIntyre · 18 years ago

Cell Therapeutics, Ready To Tap Financing (CTIC)

Cell Therapeutics (NASDAQ: CTIC) has filed an open mixed securities shelf registration for up to $150 million.  This will allow it to sell debt securities, common stock, preferred stock, and warrants.  Last Tuesday, the…

Douglas A. McIntyre · 18 years ago

Trivial Pursuit, Now All Hasbro’s (HAS)

Hasbro, Inc. (NYSE:HAS) has finally purchased all of the intellectual property rights related to the Trivial Pursuit brand from Horn Abbot Ltd. and from Horn Abbot International Ltd.  Hasbro paid out an aggregate purchase…

Douglas A. McIntyre · 18 years ago